Huntington National Bank’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Huntington National Bank’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Hold	0	–	–	–	2674
2025 Q4	–	Hold	0	–	–	–	2587
2025 Q3	–	Hold	0	–	–	–	2726
2025 Q2	–	Hold	0	–	–	–	2819
2025 Q1	–	Hold	0	–	–	–	2854
2024 Q4	–	Hold	0	–	–	–	2859
2024 Q3	–	Hold	0	–	–	–	2829
2024 Q2	–	Hold	0	–	–	–	2826
2024 Q1	–	Hold	0	–	–	–	2658
2023 Q4	–	Hold	0	–	–	–	2560
2023 Q3	–	Hold	0	–	–	–	2590
2023 Q2	–	Hold	0	–	–	–	2532
2023 Q1	–	Hold	0	–	–	–	2362
2022 Q4	–	Hold	0	–	–	–	2216

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Cetera Investment Advisers

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return